Litcius/Paper detail

Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma—Challenges and Potential Solutions

Samer Al Hadidi, Maurizio Zangari, Frits van Rhee

2022JAMA Oncology11 citationsDOI

Abstract

This Viewpoint discusses the multiple challenges that face patients and their treating oncologists when considering patients for chimeric antigen receptor T-cell therapy and assesses potential solutions.

Topics & Concepts

MedicineChimeric antigen receptorMultiple myelomaImmunologyAntigenImmunotherapyCancer researchImmune systemCAR-T cell therapy researchIntegrated Circuits and Semiconductor Failure AnalysisNanowire Synthesis and Applications
Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma—Challenges and Potential Solutions | Litcius